Concepedia

Publication | Closed Access

Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study.

117

Citations

0

References

2000

Year

Ragnar Hultborn, S. Gundersen, S. Rydén, Erik Holmberg, John Carstensen, U-B. Wallgren, S Killany, Linnea Vikane Andreassen, Göran Carlsson, N. Fahl,
PubMed

Abstract

Pamidronate 60 mg i.v. q 4 weeks reduces skeletal events and improves the quality of life in women with bone metastases from breast cancer.